Announcements Trials
Browse Landscape

Phase

Phase 2 20Phase NA 16Phase 3 10Phase 4 3Phase 1/2 3Phase 1 2

Status

Unknown 29Recruiting 19Completed 17Not yet recruiting 9Terminated 3Withdrawn 2Active not recruiting 1

Sponsor Class

INDUSTRY 649OTHER 516NIH 61NETWORK 9OTHER_GOV 3FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2Lymphoid 1

Conditions

Breast Neoplasms 2Triple Negative Breast Neoplasms 1Lymphoma, Non-Hodgkin 1HIV Infections 1

Interventions

famitinib 1dalpiciclib 1Gemcitabine 1Fulvestrant 1Everolimus 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Terminated × OTHER_GOV × Clear all
NCT05176080 2024-12-17

Famitinib Plus SHR6390 and Endocrine Therapy in the Treatment of HR-positive, HER2-negative Advanced Breast Cancer

Henan Cancer Hospital

Phase 1/2 Terminated
46 enrolled
Breast

Breast Neoplasms

NCT01939418 2017-10-03

Phase Ib/II Trials of RAD001 in Triple Negative Metastatic Breast Cancer

National Cancer Center, Korea

Phase 1/2 Terminated
23 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00432419 2011-12-22

Therapeutic Intensification of HIV-associated Non-Hodgkin's Lymphoma by Peripheral Blood Cell Transplantation Following Chemotherapy.

French National Agency for Research on AIDS and Viral Hepatitis

Phase 1/2 Terminated
1 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡